Biotechnology Biohaven Announces up to $500 Million Non-Dilutive Term Loan with Sixth Street August 7, 2020
Biotechnology Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million August 7, 2020
Health FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer’s Disease with Priority Review August 7, 2020
Press Release Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar? August 7, 2020
Search
Health
